Cubist Systematic Strategies’s Generation Bio GBIO Stock Holding History

Cubist Systematic Strategies’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,905	Closed	-$53.7K	–	3166
2024 Q2	$53.7K	Buy	1,905 +908	+91%	+$29.5K	﹤0.01%	2700
2024 Q1	$40.6K	Sell	997 -651	-40%	-$15.3K	﹤0.01%	3406
2023 Q4	$27.2K	Buy	+1,648	New	+$28.7K	﹤0.01%	3326
2023 Q2	–	Sell	-1,352	Closed	-$58.1K	–	3797
2023 Q1	$58.1K	Buy	+1,352	New	+$65.4K	﹤0.01%	3543
2022 Q4	–	Sell	-2,225	Closed	-$118K	–	4361
2022 Q3	$118K	Buy	2,225 +122	+6%	+$7.63K	﹤0.01%	3966
2022 Q2	$138K	Buy	+2,103	New	+$137K	﹤0.01%	3849
2022 Q1	–	Sell	-3,842	Closed	-$272K	–	3633
2021 Q4	$272K	Buy	3,842 +2,554	+198%	+$446K	﹤0.01%	2860
2021 Q3	$323K	Buy	+1,288	New	+$308K	﹤0.01%	2307

Other funds holding GBIO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Cubist Systematic Strategies's GBIO Position: Q3 2024 in Review

Cubist Systematic Strategies sold out of Generation Bio (GBIO) in Q3 2024, closing a stake of 1,905 shares — an estimated $53.7K sold.

Cubist Systematic Strategies first reported a position in GBIO in Q3 2021 and held it in 8 quarters. The position peaked at $323K in Q3 2021. 75 funds tracked by Wall St. Rank hold GBIO as of Q3 2024.

Cubist Systematic Strategies reported no remaining Generation Bio position as of Q3 2024 after selling out during the quarter.
Cubist Systematic Strategies sold 1,905 Generation Bio shares in Q3 2024, an estimated $53.7K.
Cubist Systematic Strategies first reported a position in Generation Bio in Q3 2021 and held it in 8 quarters.
Cubist Systematic Strategies's Generation Bio position peaked at $323K in Q3 2021.
75 funds tracked by Wall St. Rank held Generation Bio as of Q3 2024.

Based on Cubist Systematic Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.